Use of substances that act as cascade inhibitors of the Raf/MEK/ERK signal cascade, for producing a medicament to treat infections by DNA and RNA viruses
Details for Australian Patent Application No. 2001262027 (hide)
International Classifications
Event Publications
9 March 2006 Application Accepted
Published as AU-B-2001262027
6 April 2006 Corrigenda
Applications Accepted - Name Index Under the name Medinnova Gesellschaft Fur Medizinische Innovationen Aus Akademischer Forschung MbH, Application No. 2001262027, under INID (54) correct the title to read Use of substances that act as cascade inhibitors of the Raf/MEK/ERK signal cascade, for producing a medicament to treat DNA and RNA viruses. Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-RO
27 April 2006 Assignment before Grant
Medinnova Gesellschaft Fur Medizinische Innovationen Aus Akademischer Forschung MbH The application has been assigned to Activaero GmbH
6 July 2006 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser